Praxis Precision Medicines Inc. (PRAX): Price and Financial Metrics


Praxis Precision Medicines Inc. (PRAX): $4.76

0.25 (+5.54%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PRAX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

PRAX Stock Price Chart Interactive Chart >

Price chart for PRAX

PRAX Price/Volume Stats

Current price $4.76 52-week high $15.08
Prev. close $4.51 52-week low $1.48
Day low $4.48 Volume 558,628
Day high $4.81 Avg. volume 2,037,794
50-day MA $2.66 Dividend yield N/A
200-day MA $3.87 Market Cap 224.29M

Praxis Precision Medicines Inc. (PRAX) Company Bio


Praxis Precision Medicines, Inc. is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and debilitating brain disorders. The company was founded by Kiran Reddy, David Goldstein and Steven Petrou on September 22, 2015 and is headquartered in Cambridge, MA.


PRAX Latest News Stream


Event/Time News Detail
Loading, please wait...

PRAX Latest Social Stream


Loading social stream, please wait...

View Full PRAX Social Stream

Latest PRAX News From Around the Web

Below are the latest news stories about PRAXIS PRECISION MEDICINES INC that investors may wish to consider to help them evaluate PRAX as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off Tuesday with a look at the biggest pre-market stock movers that traders will want to keep an eye on today!

William White on InvestorPlace | January 17, 2023

Praxis Precision Medicines Inc. (NASDAQ: PRAX): Stock Forecast For 2023 Sees A A Decline Of -79.52%

In the last trading session, 18.48 million shares of the Praxis Precision Medicines Inc. (NASDAQ:PRAX) were traded. Most recently the company’s share price was $3.56, and it changed around $0.6 or 20.27% from the last close, which brings the market valuation of the company to $139.52M. PRAX currently trades at a discount to its 52-week … Praxis Precision Medicines Inc. (NASDAQ: PRAX): Stock Forecast For 2023 Sees A A Decline Of -79.52% Read More »

Marketing Sentinel | January 17, 2023

US Stocks Edge Lower; Bank of America Profit Tops Views

U.S. stocks traded lower this morning, with the Dow Jones dropping around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.14% to 34,141.19 while the NASDAQ fell 0.40% to 10,956.69. The S&P 500 also fell, dropping, 0.45% to 3,965.34. Check This Out: Netflix To Rally Around 18%? Here Are 10 Other Analyst Forecasts For Thursday Leading and Lagging Sectors Health care shares gained by 0.5% on Friday. Meanwhile, top gainers in the sector included Praxis Precision Medicines, Inc. (NASDAQ: PRAX ), up 45%, and Biomea Fusion, Inc. (NASDAQ: BMEA ), up 7%. In trading on Friday, financials shares fell by 1%. Top Headline Bank of America Corporation (NYSE: BAC ) reported better-than-expected earnings for its fourth quarter. Bank of America posted quarterly earnings of...

Benzinga | January 13, 2023

It would be worthwhile to take a closer look at Praxis Precision Medicines Inc. (PRAX)

The share price of Praxis Precision Medicines Inc. (NASDAQ:PRAX) rose to $2.42 per share on Thursday from $2.26. While Praxis Precision Medicines Inc. has overperformed by 7.08%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PRAX fell by -87.02%, with highs and lows ranging from $20.60 […]

US Post News | December 30, 2022

Praxis Precision Medicines and UCB collaborate for epilepsy research

Clinical-stage biopharmaceutical company, Praxis Precision Medicines (PRAX) and UCB, a global biopharmaceutical company collaborate based upon Praxis’ PRAX-020 program, for the discovery…

Seeking Alpha | December 14, 2022

Read More 'PRAX' Stories Here

PRAX Price Returns

1-mo 110.62%
3-mo 140.40%
6-mo 34.84%
1-year -63.07%
3-year N/A
5-year N/A
YTD 100.00%
2022 -87.92%
2021 -64.19%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.666 seconds.